Home > Insider Trading > Filing (0001209191-23-008065)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1564406	Oak Street Health Inc.	OSH	Services-Health Services (8000)	843446686

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1793313	M Geoffrey Price	C/O Oak Street Health, Inc. 30 W. Monroe St., Suite 1200 Chicago IL 60603	Chief Innovation Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2023-02-07	400,000	$21.00	4,274,863	No	4	M	Direct
Common Stock, $0.001 Par Value	Disposition	2023-02-07	400,000	$34.07	3,874,863	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001	Employee Stock Option (Right to Buy)	Disposition	2023-02-07	400,000	$21.00	400,000	$21.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,149,281		2030-08-05	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	1,073,270	Indirect	By Price-Uhl Living Trust

Footnotes

The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.9883 to $34.0980, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (2).
All options exercised by the Reporting Person as reported in this Form 4 were fully vested and exercisable at the time of the transaction.
The reported securities include the aggregate options, all of which were issued at the time of the Issuer's initial public offering, held by the Reporting Person, a portion of which remains subject to vesting.